Entero Therapeutics Income Tax

Entero Therapeutics (ENTO) currently reports a income tax of $-13M as of June 2026. That compares with $11M in the prior-year period — down 221.4% year over year. Use the charts on this page to explore Entero Therapeutics's income tax history and peer comparisons.

Entero Therapeutics's income tax decreased from $11M to $-13M — a 221.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Entero Therapeutics reported $-13M in income tax as of June 2026. That compares with $11M in the prior-year period — down 221.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current income tax of $-13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Entero Therapeutics, and consider following ENTO for alerts when major investors trade the stock.